Authors:
FIELDS RC
OSTERHOLZER JJ
FULLER JA
THOMAS EK
GERAGHTY PJ
MULE JJ
Citation: Rc. Fields et al., COMPARATIVE-ANALYSIS OF MURINE DENDRITIC CELLS DERIVED FROM SPLEEN AND BONE-MARROW, Journal of immunotherapy, 21(5), 1998, pp. 323-339
Authors:
CHOI D
PERRIN M
HOFFMANN S
CHANG AE
RATANATHARATHORN V
UBERTI J
MCDONAGH KT
MULE JJ
Citation: D. Choi et al., DENDRITIC CELL-BASED VACCINES IN THE SETTING OF PERIPHERAL-BLOOD STEM-CELL TRANSPLANTATION - CD34(-DEPLETED MOBILIZED PERIPHERAL-BLOOD CAN SERVE AS A SOURCE OF POTENT DENDRITIC CELLS() CELL), Clinical cancer research, 4(11), 1998, pp. 2709-2716
Citation: K. Shimizu et al., SYSTEMIC ADMINISTRATION OF INTERLEUKIN-2 ENHANCES THE THERAPEUTIC EFFICACY OF DENDRITIC CELL-BASED TUMOR VACCINES, Journal of leukocyte biology, 1998, pp. 20-20
Citation: Rc. Fields et al., MURINE DENDRITIC CELLS PULSED WITH WHOLE TUMOR LYSATES MEDIATE POTENTANTITUMOR IMMUNE-RESPONSES IN-VITRO AND IN-VIVO, Proceedings of the National Academy of Sciences of the United Statesof America, 95(16), 1998, pp. 9482-9487
Authors:
CHEN BG
SHI YJ
SMITH JD
CHOI D
GEIGER JD
MULE JJ
Citation: Bg. Chen et al., THE ROLE OF TUMOR-NECROSIS-FACTOR-ALPHA IN MODULATING THE QUANTITY OFPERIPHERAL BLOOD-DERIVED, CYTOKINE-DRIVEN HUMAN DENDRITIC CELLS AND ITS ROLE IN ENHANCING THE QUALITY OF DENDRITIC CELL-FUNCTION IN PRESENTING SOLUBLE-ANTIGENS TO CD4(-CELLS IN-VITRO() T), Blood, 91(12), 1998, pp. 4652-4661
Authors:
SHILYANSKY J
YANG JC
CUSTER MC
SPIESS P
MIXON A
COLE DJ
MULE JJ
ROSENBERG SA
NISHIMURA MI
Citation: J. Shilyansky et al., IDENTIFICATION OF A T-CELL RECEPTOR FROM A THERAPEUTIC MURINE T-CELL CLONE, Journal of immunotherapy with emphasis on tumor immunology, 20(4), 1997, pp. 247-255
Citation: Bg. Chen et al., TNF-ALPHA EXPANDS HUMAN DENDRITIC CELLS CULTURED IN SERUM-FREE MEDIUMAND ENHANCES SOLUBLE-ANTIGEN PRESENTATION TO CD4(-CELLS() T), Journal of allergy and clinical immunology, 99(1), 1997, pp. 1827-1827
Citation: Cm. Reynolds et al., ENGINEERING AN IMMUNE-RESPONSE AGAINST THE P185(HER2) TUMOR-ANTIGEN BY RETROVIRAL GENE-TRANSFER, Blood, 90(10), 1997, pp. 4624-4624
Authors:
CHOI D
WALSH M
HOFFMANN S
RATANATHARATHORN V
UBERTI J
CHANG A
MCDONAGH KT
MULE JJ
Citation: D. Choi et al., DENDRITIC CELL-BASED VACCINES IN THE SETTING OF PERIPHERAL-BLOOD STEM-CELL TRANSPLANTATION - CD34-DEPLETED MOBILIZED PERIPHERAL-BLOOD CAN SERVE AS A SOURCE OF POTENT DENDRITIC CELLS( CELL), Blood, 90(10), 1997, pp. 2399-2399
Citation: Js. Hirth et al., RAPID PURIFICATION OF ADULT HEMATOPOIETIC HUMAN STEM PROGENITOR CELLSAND USE IN GENE-THERAPY APPROACHES/, Journal of investigative medicine, 44(7), 1996, pp. 395-395
Citation: Ae. Chang et al., ADOPTIVE IMMUNOTHERAPY OF CANCER WITH ACTIVATED LYMPH-NODE CELLS PRIMED IN-VIVO WITH AUTOLOGOUS TUMOR-CELLS TRANSDUCED WITH THE GM-CSF GENE, Human gene therapy, 7(6), 1996, pp. 773-792
Authors:
GERARD CJ
ARBOLEDA MJ
SOLAR G
MULE JJ
KERR WG
Citation: Cj. Gerard et al., A RAPID AND QUANTITATIVE ASSAY TO ESTIMATE GENE-TRANSFER INTO RETROVIRALLY TRANSDUCED HEMATOPOIETIC STEM PROGENITOR CELLS USING A 96-WELL FORMAT PCR AND FLUORESCENT DETECTION SYSTEM UNIVERSAL FOR MMLV-BASED PROVIRUSES, Human gene therapy, 7(3), 1996, pp. 343-354
Authors:
MULE JJ
CUSTER M
AVERBOOK B
YANG JC
WEBER JS
GOEDDEL DV
ROSENBERG SA
SCHALL TJ
Citation: Jj. Mule et al., RANTES SECRETION BY GENE-MODIFIED TUMOR-CELLS RESULTS IN LOSS OF TUMORIGENICITY IN-VIVO - ROLE OF IMMUNE CELL SUBPOPULATIONS, Human gene therapy, 7(13), 1996, pp. 1545-1553
Authors:
DIGIUSTO DL
LEE R
MOON J
MOSS K
OTOOLE T
VOYTOVICH A
WEBSTER D
MULE JJ
Citation: Dl. Digiusto et al., HEMATOPOIETIC POTENTIAL OF CRYOPRESERVED AND EX-VIVO MANIPULATED UMBILICAL-CORD BLOOD PROGENITOR CELLS EVALUATED IN-VITRO AND IN-VIVO, Blood, 87(4), 1996, pp. 1261-1271
Authors:
MARINCOLA FM
SHAMAMIAN P
SIMONIS TB
ABATI A
HACKETT J
ODEA T
FETSCH P
YANNELLI J
RESTIFO NP
MULE JJ
ROSENBERG SA
Citation: Fm. Marincola et al., LOCUS-SPECIFIC ANALYSIS OF HUMAN-LEUKOCYTE ANTIGEN CLASS-I EXPRESSIONIN MELANOMA CELL-LINES, Journal of immunotherapy with emphasis on tumor immunology, 16(1), 1994, pp. 13-23
Authors:
MARCUS SG
PERRYLALLEY D
MULE JJ
ROSENBERG SA
YANG JC
Citation: Sg. Marcus et al., THE USE OF INTERLEUKIN-6 TO GENERATE TUMOR-INFILTRATING LYMPHOCYTES WITH ENHANCED IN-VIVO ANTITUMOR-ACTIVITY, Journal of immunotherapy with emphasis on tumor immunology, 15(2), 1994, pp. 105-112
Authors:
MARINCOLA FM
ETTINGHAUSEN S
COHEN PA
CHESHIRE LB
RESTIFO NP
MULE JJ
ROSENBERG SA
Citation: Fm. Marincola et al., TREATMENT OF ESTABLISHED LONG METASTASES WITH TUMOR-INFILTRATING LYMPHOCYTES DERIVED FROM A POORLY IMMUNOGENIC TUMOR ENGINEERED TO SECRETE HUMAN TNF-ALPHA, The Journal of immunology, 152(7), 1994, pp. 3501-3513
Authors:
COHEN PJ
COHEN PA
ROSENBERG SA
KATZ SI
MULE JJ
Citation: Pj. Cohen et al., MURINE EPIDERMAL LANGERHANS CELLS AND SPLENIC DENDRITIC CELLS PRESENTTUMOR-ASSOCIATED ANTIGENS TO PRIMED T-CELLS, European Journal of Immunology, 24(2), 1994, pp. 315-319
Citation: Pa. Cohen et al., CD4(-CELLS FROM MICE IMMUNIZED TO SYNGENEIC SARCOMAS RECOGNIZE DISTINCT, NON-SHARED TUMOR-ANTIGENS() T), Cancer research, 54(4), 1994, pp. 1055-1058
Authors:
COHEN PA
KIM H
FOWLER DH
GRESS RE
JAKOBSEN MK
ALEXANDER RB
MULE JJ
CARTER C
ROSENBERG SA
Citation: Pa. Cohen et al., USE OF INTERLEUKIN-7, INTERLEUKIN-2, AND INTERFERON-GAMMA TO PROPAGATE CD4-CELLS IN CULTURE WITH MAINTAINED ANTIGEN-SPECIFICITY( T), Journal of immunotherapy with emphasis on tumor immunology, 14(3), 1993, pp. 242-252
Authors:
SHILONI E
KARP SE
CUSTER MC
SHILYANSKY J
RESTIFO NP
ROSENBERG SA
MULE JJ
Citation: E. Shiloni et al., RETROVIRAL TRANSDUCTION OF INTERFERON-GAMMA CDNA INTO A NONIMMUNOGENIC MURINEFIBROSARCOMA - GENERATION OF T-CELLS IN DRAINING LYMPH-NODES CAPABLE OF TREATING ESTABLISHED PARENTAL METASTATIC TUMOR, Cancer immunology and immunotherapy, 37(5), 1993, pp. 286-292